PSY-PGx Group for Mood Disorders
This trial will test if personalized medicine helps psychiatric patients better than usual treatments.
- Mood Disorders
- Anxiety Disorders
2 Primary · 10 Secondary · Reporting Duration: 24 weeks
2 Treatment Groups
Dosing as usual (DAU) group
1 of 2
1 of 2
2500 Total Participants · 2 Treatment Groups
Primary Treatment: PSY-PGx Group · No Placebo Group · N/A
Who is running the clinical trial?
Age 16 - 65 · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is eligibility for this research project confined to individuals below the age of 45?
"This clinical trial's parameters stipulate that the participating patient must be between 16 and 65 years of age. Simultaneously, there are 422 studies being conducted for minors and 1033 trials taking place with seniors as participants." - Anonymous Online Contributor
Is enrollment into this experiment still open?
"According to records hosted on clinicaltrials.gov, this specific trial is no longer recruiting participants; the initial post date was December 1st 2022 with a recent update occurring on the 9th of that month. Fortunately, there are presently 1588 other trials searching for volunteers across the world." - Anonymous Online Contributor
Is it possible to join this medical experiment?
"This trial is seeking 2500 individuals aged 16 to 65 who suffer from a mental health condition, such as major depressive disorder, bipolar disorder (with current episode of depression), panic disorder or generalised anxiety disorder. Such participants must have had an inadequate response to at least one psychotropic treatment and are currently receiving inpatient or outpatient psychiatric care. Furthermore, they should be willing to switch their medication either sertraline/escitalopram for mood/anxiety disorders or aripiprazole/risperidone for psychotic disorders within the last 2 weeks prior to contact with an investigator. Finally, applicants need possess basic understanding about this" - Anonymous Online Contributor